KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Steris (STE) Change in Receivables (2018 - 2025)

Historic Change in Receivables for Steris (STE) over the last 8 years, with Q4 2025 value amounting to $15.5 million.

  • Steris' Change in Receivables rose 38437.5% to $15.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.7 million, marking a year-over-year decrease of 6816.53%. This contributed to the annual value of $28.8 million for FY2025, which is 7750.04% down from last year.
  • Steris' Change in Receivables amounted to $15.5 million in Q4 2025, which was up 38437.5% from $5.3 million recorded in Q3 2025.
  • Steris' Change in Receivables' 5-year high stood at $109.8 million during Q1 2024, with a 5-year trough of -$119.2 million in Q2 2025.
  • Moreover, its 5-year median value for Change in Receivables was $20.5 million (2023), whereas its average is $14.6 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 84373.02% in 2021, then crashed by 15373.42% in 2024.
  • Quarter analysis of 5 years shows Steris' Change in Receivables stood at -$5.6 million in 2021, then skyrocketed by 637.71% to $29.9 million in 2022, then tumbled by 47.2% to $15.8 million in 2023, then crashed by 79.73% to $3.2 million in 2024, then soared by 384.38% to $15.5 million in 2025.
  • Its last three reported values are $15.5 million in Q4 2025, $5.3 million for Q3 2025, and -$119.2 million during Q2 2025.